ConductScience.org, home

Paper40480232

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy.

Benton A and 11 others. Cancer Cell, 2025. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy. Papers, record 40480232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40480232

Download JSON
Cell line
HEK293T2,726 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy.
PubMed
Journal
Cancer Cell
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
6.03, provisional
iCite
Revised in PubMed
2026-07-26
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Benton AAlexander
2Liu JJiageng
3Poussin MAMathilde A
4Lang Goldgewicht AAndrea
5Udawela MMadhara
6Bear ASAdham S
7Wellhausen NNils
8Carreno BMBeatriz M
9Smith PMPete M
10Beasley MDMatthew D
11Kiefel BRBen R
12Powell DJ JrDaniel J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunotherapy, AdoptiveMajor topic
Receptors, Chimeric AntigenMajor topic
Proto-Oncogene Proteins p21(ras)Major topic
MutationMajor topic
T-LymphocytesMajor topic
Receptors, Antigen, T-CellMajor topic
NeoplasmsMajor topic
Humans
Animals
Mice
Xenograft Model Antitumor Assays
Cell Line, Tumor
Peptides
Lung Neoplasms

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA260902NCI NIH HHSUnited StatesR01CA260902PubMed and NIHNIH RePORTER
R01 EB026892NIBIB NIH HHSUnited StatesR01EB026892PubMed and NIHNIH RePORTER
T32 GM008076NIGMS NIH HHSUnited StatesT32GM008076PubMedNIH RePORTER

Download CSV of grants

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137938771Targeting of intracellular oncoproteins with peptide-centric CARs.Nature2023https://conductscience.org/library/papers/37938771PubMed
236203573IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines.Front Immunol2022https://conductscience.org/library/papers/36203573PubMed
328676342Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase.Mol Ther2017https://conductscience.org/library/papers/28676342PubMed
436732477Synapse-tuned CARs enhance immune cell anti-tumor activity.Nat Biotechnol2023https://conductscience.org/library/papers/36732477PubMed
529707912Cell Surface MHC Class I Expression Is Limited by the Availability of Peptide-Receptive "Empty" Molecules Rather than by the Supply of Peptide Ligands.Proteomics2018https://conductscience.org/library/papers/29707912PubMed
631501612Clinical lessons learned from the first leg of the CAR T cell journey.Nat Med2019https://conductscience.org/library/papers/31501612PubMed
736629052Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cells.Clin Transl Med2023https://conductscience.org/library/papers/36629052PubMed
829055006Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip.J Immunol2017https://conductscience.org/library/papers/29055006PubMed
97636241Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation.J Immunol1995https://conductscience.org/library/papers/7636241PubMed
1035474673Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations.Cell Rep Methods2021https://conductscience.org/library/papers/35474673PubMed
1129282079Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues.BMC Cancer2017https://conductscience.org/library/papers/29282079PubMed
1231207478Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours.Cancer Treat Rev2019https://conductscience.org/library/papers/31207478PubMed
1331142602Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma.J Immunol2019https://conductscience.org/library/papers/31142602PubMed
1429123084Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.Nat Commun2017https://conductscience.org/library/papers/29123084PubMed
1521830940Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.N Engl J Med2011https://conductscience.org/library/papers/21830940PubMed
1631798590Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies.Front Immunol2019https://conductscience.org/library/papers/31798590PubMed
1734936383An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma.Sci Transl Med2021https://conductscience.org/library/papers/34936383PubMed
189326219Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.Blood1997https://conductscience.org/library/papers/9326219PubMed
1930135176Tumor Antigen Escape from CAR T-cell Therapy.Cancer Discov2018https://conductscience.org/library/papers/30135176PubMed
2029242379High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.Mol Cell Proteomics2018https://conductscience.org/library/papers/29242379PubMed

See all 59 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42393377A guide to CAR T cell therapies: development, current status and future prospects.Nat Rev Immunol2026https://conductscience.org/library/papers/42393377PubMed
42365891Multi-dimensional orchestration of binders for improved CAR-T immunotherapy.Cancer Lett2026https://conductscience.org/library/papers/42365891PubMed
42200804Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.Cancer Res2026https://conductscience.org/library/papers/42200804PubMed
42185131The evolution of display technologies for antibody drug discovery.Trends Biotechnol2026https://conductscience.org/library/papers/42185131PubMed
42078371A catalogue of missense and nonsense mutation abundances for the U.S. cancer patient population.medRxiv2026https://conductscience.org/library/papers/42078371PubMed
42039159CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors.Front Immunol2026https://conductscience.org/library/papers/42039159PubMed
41977251Immune Escape in Renal Cell Carcinoma: Latest Research and Treatment Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/41977251PubMed
41939454Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions.Front Oncol2026https://conductscience.org/library/papers/41939454PubMed
41930147Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.Oncol Res2026https://conductscience.org/library/papers/41930147PubMed
41719389KRASG12V/HLA-A*02:01-targeted chimeric antigen receptor T cells exhibit potent preclinical activity against solid tumors.Sci Adv2026https://conductscience.org/library/papers/41719389PubMed
41635856Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy.Front Immunol2025https://conductscience.org/library/papers/41635856PubMed
41408054Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy.Nat Commun2025https://conductscience.org/library/papers/41408054PubMed
41354926Improving CAR T cell therapy against malignancies through gene knock-down/out strategies: a systematic review.Cancer Cell Int2025https://conductscience.org/library/papers/41354926PubMed
41309533Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41309533PubMed
40945517CAR-T cells in solid tumors: Challenges and breakthroughs.Cell Rep Med2025https://conductscience.org/library/papers/40945517PubMed
40809405The next generation of dental treatments: Leveraging smart-responsive nanomaterials for unique oral environments.Mater Today Bio2025https://conductscience.org/library/papers/40809405PubMed
40672284A pan-cancer atlas of therapeutic T cell targets.bioRxiv2025https://conductscience.org/library/papers/40672284PubMed
40500372A cancer-causing mutation meets its match.Nature2025https://conductscience.org/library/papers/40500372PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40480232

GET https://conductscience.org/api/papers/v1/40480232/references?page=2